» Authors » Rune Jemtland

Rune Jemtland

Explore the profile of Rune Jemtland including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 317
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Jemtland R, Holden M, Reppe S, Olstad O, Reinholt F, Gautvik V, et al.
J Bone Miner Res . 2011 Apr; 26(8):1793-801. PMID: 21452281
Genome-wide gene expressions in bone biopsies from patients with postmenopausal osteoporosis and healthy controls were profiled, to identify osteoporosis candidate genes. All osteoporotic patients (n = 27) in an unbiased...
3.
Reppe S, Refvem H, Gautvik V, Olstad O, Hovring P, Reinholt F, et al.
Bone . 2009 Nov; 46(3):604-12. PMID: 19922823
Low bone mineral density (BMD) is an important risk factor for skeletal fractures which occur in about 40% of women >/=50 years in the western world. We describe the transcriptional...
4.
Lekva T, Bollerslev J, Kristo C, Olstad O, Ueland T, Jemtland R
J Clin Endocrinol Metab . 2009 Oct; 95(1):246-55. PMID: 19875485
Context: Glucocorticoid-induced bone loss is a serious complication in patients with endogenous Cushing's syndrome. However, the mechanism(s) by which excess glucocorticoids influence bone metabolism is not completely understood. Objective: The...
5.
Pedersen M, Fortunati D, Nielsen M, Brorson S, Lekva T, Nissen-Meyer L, et al.
Bone . 2008 Jul; 43(4):700-7. PMID: 18620088
The Ca(2+)/Calmodulin-dependent protein kinase (CaMK) family is activated in response to elevation of intracellular Ca(2+), and includes CaMK1 (as well as CaMK2 and CaMK4), which exists as different isoforms (alpha,...
6.
Lyngstad-Brechan M, Tauboll E, Otto Nakken K, Gjerstad L, Godang K, Jemtland R, et al.
Scand J Clin Lab Invest . 2008 Jul; 68(8):759-66. PMID: 18618370
Objectives: The aims of this study were to assess the occurrence of osteoporosis and fracture rate in Norwegian postmenopausal women with epilepsy using antiepileptic drugs (AEDs), and to investigate how...
7.
Nissen-Meyer L, Svalheim S, Tauboll E, Gjerstad L, Reinholt F, Jemtland R
Seizure . 2008 Jan; 17(2):187-91. PMID: 18180177
Patients with epilepsy, treated with antiepileptic drugs (AEDs) are at increased risk of fractures. Although several commonly used AEDs reduce bone mass in patients, the mechanisms are only scarcely known....
8.
Nissen-Meyer L, Jemtland R, Gautvik V, Pedersen M, Paro R, Fortunati D, et al.
J Cell Sci . 2007 Jul; 120(Pt 16):2785-95. PMID: 17652162
The transcription factor Sox4 is vital for fetal development, as Sox4(-/-) homozygotes die in utero. Sox4 mRNA is expressed in the early embryonic growth plate and is regulated by parathyroid...
9.
Nissen-Meyer L, Svalheim S, Tauboll E, Reppe S, Lekva T, Solberg L, et al.
Epilepsia . 2007 Jul; 48(10):1850-60. PMID: 17634065
Purpose: Long-term treatment with antiepileptic drugs (AEDs) is associated with increased risk of fractures. Phenytoin (PHT) and valproate (VPA) have both been suggested to influence bone health, whereas levetiracetam (LEV)...
10.
Kristo C, Jemtland R, Ueland T, Godang K, Bollerslev J
Eur J Endocrinol . 2005 Dec; 154(1):109-18. PMID: 16381999
Objective: Endogenous Cushing's syndrome (CS) is associated with bone loss and an increased risk of fractures. However, the long-term outcome of treatment on bone health has not been adequately clarified....